Twenty-five years clinical trials of the German Hodgkin Study Group (GHSG).
This review presents a short overview of 25-years of clinical trials by the GHSG for the treatment of primary Hodgkin's Lymphoma. The trials HD1-HD12 that have been conducted between 1978-2002 are reviewed and major results are discussed. Furthermore, the development of the strategies concerning chemo- and radiotherapy for the treatment of Hodgkin's Lymphoma is characterized.
Behringer
K
K
Diehl
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000266:history; D016022:Case-Control Studies; D017321:Clinical Trials, Phase I as Topic / Q000266:history; D017322:Clinical Trials, Phase II as Topic / Q000266:history; D003131:Combined Modality Therapy / Q000266:history; D005260:Female; D049673:History, 20th Century; D049674:History, 21st Century; D006689:Hodgkin Disease / Q000266:history / Q000628:therapy*; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged